Comparison 7. Type of platinum agent.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
7.1 Disease‐free survival	13	3347	Hazard Ratio (IV, Fixed, 95% CI)	0.65 [0.56, 0.74]
7.1.1 Carboplatin	12	3222	Hazard Ratio (IV, Fixed, 95% CI)	0.65 [0.57, 0.75]
7.1.2 Lobaplatin	1	125	Hazard Ratio (IV, Fixed, 95% CI)	0.21 [0.05, 0.98]
7.2 Overall survival	12		Hazard Ratio (IV, Fixed, 95% CI)	Subtotals only
7.2.1 Carboplatin	12	3229	Hazard Ratio (IV, Fixed, 95% CI)	0.69 [0.58, 0.83]
7.3 Pathological complete response	16	3148	Risk Ratio (M‐H, Fixed, 95% CI)	1.46 [1.33, 1.61]
7.3.1 Carboplatin	13	2801	Risk Ratio (M‐H, Fixed, 95% CI)	1.45 [1.32, 1.60]
7.3.2 Cisplatin	2	222	Risk Ratio (M‐H, Fixed, 95% CI)	1.00 [0.58, 1.75]
7.3.3 Lobaplatin	1	125	Risk Ratio (M‐H, Fixed, 95% CI)	3.05 [1.48, 6.26]